クローン病：企業動向...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 9
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers – Global Issues 17
4 Current and Future Players 22
4.1 Overview 22
4.2 Trends in Corporate Strategy 24
4.3 Company Profiles 26
4.3.1 Johnson & Johnson 26
4.3.2 AbbVie 28
4.3.3 UCB 30
4.3.4 Biogen Idec 31
4.3.5 Takeda 33
4.3.6 ChemoCentryx 35
5 Appendix 37
5.1 Bibliography 37
5.2 Abbreviations 38
5.3 Methodology 40
5.4 Forecasting Methodology 40
5.4.1 Diagnosed CD Patients 40
5.4.2 Percent Drug-Treated Patients 41
5.4.3 General Pricing Assumptions 41
5.4.4 Generic Erosion 42
5.4.5 Physicians and Specialists Included in This Study 43
5.5 Primary Research – Prescriber Survey 45
5.6 About the Authors 46
5.6.1 Author/Reviewer 46
5.6.2 Global Head of Healthcare 46
5.7 About GlobalData 47
5.8 Disclaimer 47